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ing collagen IV. It is widely expressed during embryogenesis, and in vitro studies have suggested roles in
the regulation of cell adhesion and proliferation, and in the modulation of cytokine activity. In order to
analyse the function of this protein in vivo, the endogenous Sparc locus was disrupted by homologous re-
combination in murine embryonic stem cells. SPARC-deficient mice (Sparctm1Cam) appear normal and
fertile until around 6 months of age, when they develop severe eye pathology characterized by cataract
formation and rupture of the lens capsule. The first sign of lens pathology occurs in the equatorial
bow region where vacuoles gradually form within differentiating epithelial cells and fibre cells. The lens
capsule, however, shows no qualitative changes in the major basal lamina proteins laminin, collagen IV,
perlecan or entactin. These mice are an excellent resource for further studies on how SPARC affects cell
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SPARC (secreted protein acidic and rich in cysteine,
also known as osteonectin/BM40) is a secreted Ca21-
binding glycoprotein that interacts with a range of
extracellular matrix molecules, including collagen IV. It
is widely expressed during embryogenesis, and in vitro
studies have suggested roles in the regulation of
cell adhesion and proliferation, and in the modulation
of cytokine activity. In order to analyse the function
of this protein in vivo, the endogenous Sparc locus
was disrupted by homologous recombination in
murine embryonic stem cells. SPARC-deficient mice
(Sparctm1Cam) appear normal and fertile until around 6
months of age, when they develop severe eye pathology
characterized by cataract formation and rupture of
the lens capsule. The first sign of lens pathology occurs
in the equatorial bow region where vacuoles gradually
form within differentiating epithelial cells and fibre
cells. The lens capsule, however, shows no qualitative
changes in the major basal lamina proteins laminin,
collagen IV, perlecan or entactin. These mice are an
excellent resource for further studies on how SPARC




SPARC (secreted protein acidic and rich in cysteine, also
known as osteonectin/BM40) is a secreted Ca21-binding
glycoprotein (Mr 43 kDa) which can interact with several
extracellular matrix (ECM) molecules and cytokines (for
review, see Lane and Sage, 1994). Ca21 is bound by two
regions within the protein; an acidic N-terminal domain
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and a C-terminal domain containing two EF hand motifs
(Hohenester et al., 1996). The protein was first purified
as a major non-collagenous component of bovine bone,
with binding affinity to collagen I (Termine et al., 1981),
and was cloned independently as a major product of
mouse parietal endoderm cells (Mason et al., 1986a,b).
SPARC is widely expressed in many different tissues and
cell types in both embryonic and adult mice, often at high
levels. The high sequence conservation between species,
with mammalian (Termine et al., 1981; Mason et al.,
1986b), amphibian (Damjanovski et al., 1992) and avian
(Iruela-Arispe et al., 1995) SPARC showing .70% amino
acid identity, suggests that the protein has an important
physiological role. SPARC expression appears to be
restricted to sites of high cell proliferation, matrix
remodelling and epithelial–mesenchymal interactions, sug-
gesting a role in these processes (Holland et al., 1987;
Howe et al., 1988; Sage et al., 1989a; Tremble et al.,
1993). Indeed, a variety of in vitro studies have shown
that secretion of SPARC, or specific structural domains
of the protein, affects cell morphology by reducing the
number of focal contacts and lowering adhesion to the
substratum and to neighbouring cells (Sage et al., 1984;
Lane and Sage, 1990). This type of ‘anti-adhesive’ function
has also been described for the secreted proteins tenascin
and thrombospondin, and purified SPARC protein binds
to many ECM components such as thrombospondin and
collagens I and IV (Sage et al., 1989b).
Sparc expression is up-regulated in transformed cells
(Mason et al., 1986b), and increased expression is also
associated with the neoplastic progression of several
human tumour types (Bellahcene and Castronovo, 1995;
Porter et al., 1995). Moreover, a recent study shows that
suppression of Sparc expression using antisense RNA
significantly decreases the tumorigenicity of human
melanoma cells by reducing their invasive and adhesive
properties (Ledda et al., 1997). In addition to its anti-
adhesive effect, SPARC may also have a role in modulating
polypeptide signalling. SPARC contains a follistatin-
related structural motif which is thought to be involved
in growth factor binding (Patthy and Nickolics, 1993). In
addition, in vitro studies have shown that SPARC binds
to specific dimeric forms of platelet-derived growth factor
(PDGF) and prevents them from interacting with their
receptors (Raines et al., 1992). Since SPARC and the
PDGF-B chain are co-expressed in both platelet α granules
and at sites of arterial injury, SPARC may regulate the
activity of at least one cytokine in vivo.
To examine the role of SPARC in embryonic develop-
ment, we have inactivated the murine Sparc locus by
homologous recombination in embryonic stem (ES) cells.
Although previous reports have suggested an important
role for SPARC homologues or SPARC-related proteins
in the embryonic development of other species (Purcell
Loss of SPARC causes cataracts
Fig. 1. Sparc targeting strategy. The top line shows the targeting vector pS2. The marker SA β-gal/PGKneo is shown as a box, where the β-gal
coding sequence is stippled and the PGKneo marker cassette and splice acceptor sequences are unfilled. The middle line shows the region of the
wild-type Sparc gene covering exons 5–9 (striped boxes). Finally, the bottom line shows the disrupted Sparc allele resulting from targeted integration
of vector pS2. The positions of the probes used to verify targeting are indicated by thick horizontal bars. Targeting leads to the replacement of exon
6 with the disruptive marker and a concomitant size increase in the BamHI and PstI fragments which hybridize to the E1300 external probe.
Restriction enzyme sites: B, BamHI; P, PstI; E, EcoRI; H, HindIII.
et al., 1993; Schwarzbauer and Spencer, 1993), SPARC-
deficient mice (Sparctm1Cam) develop normally, are fertile
and initially are indistinguishable from wild-type litter-
mates. Histological analysis of mice older than 6 months
of age, however, reveals abnormal vacuolation of lens
fibre cells, followed by extensive disorganization of the
lens structure including posterior migration of epithelial
cells and possibly delayed epithelial cell differentiation
into lens fibres. These changes are accompanied by late
stage posterior rupture of the lens capsule. This suggests
that SPARC plays an important role in maintaining lens
homeostasis and capsule integrity, which may account for
the high degree of evolutionary conservation of this protein
among vertebrates.
Results
Generation of SPARC-deficient mice
The approach used to disrupt the Sparc gene is outlined
in Figure 1. Homologous recombination with the targeting
vector pS2 results in the replacement of exon 6 with a splice
accepting marker, SA β-gal, and a neomycin resistance
cassette (Friedrich and Soriano, 1991). This event deletes
half of the follistatin module (Patthy and Nickolics, 1993)
and causes premature termination of transcription and
translation, resulting in the removal of downstream
domains which are known to be required for proper folding
and secretion of the protein (Pottgiesser et al., 1994).
Targeted ES clones were identified using a 39 probe
external to the targeting vector (Figure 2A), and targeting
was confirmed by hybridization to an internal neo probe.
Chimaeras derived from targeted ES cells transmitted the
disrupted Sparc allele through the germline.
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SPARC is not essential for normal development
Heterozygous Sparctm1Cam mice appeared normal, and
intercrossing of these animals produced viable homo-
zygous offspring (Figure 2B). Statistical analysis of 95
offspring indicated no significant deviation from the
expected Mendelian ratio of genotypes (20 1/1, 54 1/–,
21 –/–). Southern analysis of DNA from these animals
with an exon 6 probe, as well as with the external E1300
probe and internal neo probe, confirmed that exon 6 had
been replaced by the targeting vector (Figure 2C). In
addition, an exon 6-specific PCR designed for genotyping
Sparctm1Cam mutant mice consistently gave a PCR product
for heterozygous and wild-type mice, but never for
Sparctm1Cam homozygous null mice (data not shown). This
confirms that exon 6 is deleted from the genome of
Sparctm1Cam mutant mice.
To prove that transcription of the Sparc gene was
disrupted in the homozygous mutant animals, RNA was
made from 15 d.p.c. embryos of all three genotypes, and
these samples were analysed by Northern blotting (Figure
3A). Probing with cDNA fragments representing
sequences downstream (probe EP290) and upstream (probe
C33i) of the replacement site showed that although there
are high levels of Sparc transcription in the wild-type and
heterozygous embryos, no Sparc mRNA could be detected
in homozygous mutant embryos. The absence of a trunc-
ated transcript upstream of the site of marker integration
was confirmed by probing the RNA samples with the
complete Sparc cDNA sequence (data not shown). It is
likely that the fusion transcript resulting from insertion of
the marker construct is unstable. In addition, Western blot
analysis of protein from the testes of Sparctm1Cam mutant
mice confirmed that no SPARC is produced (Figure 3B).
D.T.Gilmour et al.
Fig. 2. Generation of SPARC-deficient mice. (A) Identification of ES cells carrying a mutated Sparc allele. ES cell DNA was digested with BamHI
and probed with the external fragment E1300. Shown here is an example of an ES cell clone revealing the fragment size increase characteristic of a
targeting event. (B) Southern blot of tail DNA from 2-week-old offspring derived from the crosses of Sparctm1Cam heterozygous mice (1/–).
Genomic DNA was digested with BamHI and probed with the external fragment E1300. This blot shows the presence of viable pups which are
homozygous for the targeted Sparc allele (–/–). (C) Confirmation that exon 6 has been deleted in the homozygous mutants. The left hand blot shows
tail DNA from wild-type (1/1), heterozygous (1/–) and homozygous (–/–) offspring digested with BamHI or PstI and probed with E1300. This blot
was stripped and probed with marker-specific probe neo (middle panel). As expected, this gives a band only in the heterozygous and homozygous
lanes, the latter being more intense. Finally, probing of this blot with the Sparc exon 6 gives a strong band in the wild-type lane, a band of roughly
half this intensity in heterozygotes and a complete lack of the band in homozygotes, proving deletion of this exon in the mutant mice. The presence
of the second band when the wild-type PstI digest is probed with exon 6 was shown to be due a restriction fragment length polymorphism between
the strains of mice used to generate these animals (129/SvEv and MF1).
Although SPARC has been implicated in the morpho-
genesis of many tissues and organs such as bone, muscle,
blood vessels, skin, kidney, testes, ovary and heart (Holland
et al., 1987; Sage et al., 1989a; Engelmann, 1993; Nakase
et al., 1994), histological examination of these tissues
from adult mutant animals did not reveal obvious defects
(not shown). In addition, alizarin red staining of bone
preparations from adults showed that the cranial, axial
and appendicular skeletons of mutant animals were indis-
tinguishable from those of non-mutant littermates (Figure
4). Sparctm1Cam mutant males are fully fertile, even though
SPARC is secreted by Leydig and Sertoli cells in the adult
mouse testis (Vernon and Sage, 1989).
SPARC-deficient mice develop cataracts
Beginning around 6 months of age, many of the
Sparctm1Cam homozygous mice on a mixed genetic back-
ground (129/SvEv3MF1) began to develop visible catar-
acts. This was first observed in albino mice where it was
easier to see the initial eye opacity characteristic of
cataract formation (Figure 5A). Initial histological analysis
revealed that the lenses from Sparctm1Cam mutant mice had
undergone major architectural disorganization to form sub-
capsular cataracts (Figure 5B). The majority of the SPARC-
deficient mice began to develop cataracts after 6 months
of age. These results are summarized in Table I. A total
of 75 Sparctm1Cam null mice, ranging in age from 3 to 18
months, were analysed either histologically or by visual
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inspection post-mortem after pupil dilation. Of 51
Sparctm1Cam null mice aged 10–20 months, all showed
severe bilateral cataracts. In the age range of 6–9 months,
17/18 Sparctm1Cam null mice had developed more subtle
but clear bilateral cataracts (usually without posterior lens
rupture but including extensive lens fibre vacuolation).
Mutant animals ,6 months old showed lens structures
indistinguishable from wild-type mice. In contrast, out of
a total of 30 heterozygous or wild-type littermates or age-
matched controls of similar genetic background, ranging
from 2 to 18 months of age, none showed bilateral cataract
development.
The gross appearance of the eyes from 1-year-old albino
wild-type and Sparctm1Cam mutant mice is shown in Figure
5A. The opacity in the eyes of Sparctm1Cam mutant mice
was obvious by visual inspection, especially post-mortem
after pupil dilation. Histological analysis of eyes from
wild-type (Figure 5B, panels a, c and e) and Sparctm1Cam
mutant mice (Figure 5B, panels b, d and f) showed a
dramatic difference in lens structure due to the develop-
ment of a sub-capsular cataract with subsequent posterior
rupture of the lens in mutant mice. In Figure 5B, panel c,
the normal equatorial bow of epithelial cells migrating
inward away from the capsule region is shown in a wild-
type mouse lens. In Figure 5B, panel d, the bow region from
a Sparctm1Cam mutant mouse shows severe disorganization,
with cell vacuolation and a lack of coherent bowing of
epithelial cells. In Figure 5B, panels e and f, the posterior
Loss of SPARC causes cataracts
Fig. 3. Confirmation of null phenotype by Northern and Western blotting. (A) Northern analysis confirming the absence of Sparc mRNA. Total
embryonic RNA from 15 d.p.c. embryos of all three genotypes was analysed using probes 59 (EP390) or 39 (c33i) to the insertion point. Blots were
re-probed with β-actin to confirm equal RNA loadings between lanes. (B) Western analysis confirming the absence of SPARC protein. SPARC
protein was detected in the testes of wild-type (1/1) but not mutant animals (–/–) using a purified polyclonal rabbit antibody (1064 1E). Equivalent
protein loading in each lane was confirmed by visualization with a monoclonal β-actin antibody.
region of wild-type and Sparctm1Cam mutant mouse lenses
are shown. In the mature wild-type lens, there are no
epithelial cells present in this region. However, this is not
the case in the Sparctm1Cam mutant mouse lens, as this
region is infiltrated with epithelial cells (arrowed, Figure
5B, panel f).
The lenses from one Sparctm1Cam mutant mouse at 18
months with different cataract severity in each eye were
examined to gain an insight into the time course of cataract
formation (Figure 6). In the least severely affected eye,
there was extensive vacuolation both in differentiating
epithelial cells and in lens fibre cells (Figure 6a and b).
The normal arrangement of epithelial cells at the equatorial
bow region was disrupted by this vacuolation (Figure
6a). In the more severely affected eye, vacuolation and
degeneration of lens fibres along with rupture of the
basement membrane was seen (Figure 6c, arrowed). This
eye also showed severe disruption of the retinal layer,
which is secondary to the dramatic disorganization and
deterioration of the lens (Figure 6d, arrowed).
Electron microscopy studies revealed striking abnorm-
alities in the posterior and equatorial regions of lenses
from Sparctm1Cam mutant mice (Figure 7). Abnormal pro-
trusions of electron-dense material, possibly cellular
debris, in the posterior capsule of Sparctm1Cam mutant
mice were observed (Figure 7b). In addition, the normal
concentric arrangement of the lens fibres was often dis-
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organized close to the capsule region (not shown). In the
anterior part of the lens, epithelial cells showed abnormal
rounding (Figure 7d, arrowed) compared with their usual
elongated appearance (Figure 7c, arrowed). Vacuolation
was particularly pronounced in the bow region (Figure
7f), and this region was also characterized by extensive
cellular debris (Figure 7e), perhaps from ruptured lens
cells.
No major qualitative changes are found in
capsular extracellular matrix proteins
To understand the mechanism of lens degeneration in
SPARC-deficient mice, capsules were assessed for changes
in the deposition and expression of major ECM proteins
by immunohistochemistry (Figure 8). No qualitative differ-
ences were found between Sparctm1Cam mutant and wild-
type mice using polyclonal antibodies to laminin 1 or
collagen α1,2(IV), or monoclonal antibodies to perlecan
or entactin. These are the major components of basal
laminae throughout the body. In addition, no differences
were observed between mutant and control animals for
these ECM components in other basal laminae in the eye
(cornea, retina, extra-ocular muscle, Figure 8f and l and
data not shown). Further studies with antibodies for
laminin subunits also failed to reveal differences: both
control and mutant lens capsules were rich in the α1, α5,
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Fig. 4. Skeletal analysis. Alizarin red and Alcian blue staining of heterozygous (1/–) and Sparctm1Cam mutant (–/–) mice showing no obvious
differences in skeletal structure.
β1 and γ1 chains, and contained low but detectable levels
of α2 and β2 (data not shown).
Discussion
Abnormal lens morphology in mutant mice
We have shown that SPARC-deficient mice appear normal
and fertile until around 6 months of age, when they
develop severe eye pathology characterized by cataract
formation and rupture of the lens. Prior to this age, lenses
appear histologically normal, suggesting that the initial
morphogenesis of the lens and the organization of the
epithelial cells in relation to the capsule are not com-
promised. The first distinguishable signs of lens pathology
are observed around 6 months of age in the equatorial
bow region of the eye, where vacuoles gradually form
within differentiating epithelial cells and fibre cells. This
vacuolation process might reflect abnormal differentiation
of sub-capsular epithelial cells. In wild-type mice, anterior
lens epithelial cells differentiate into secondary fibre cells
at the equatorial bow region, losing their nuclei during this
process. In the Sparctm1Cam mutant mice, this differentiation
process is abnormal, with the nuclei appearing more
rounded and the cells in the bow region more disorganized.
Interestingly, quail retina protein (QR1), which has strong
C-terminal homology to SPARC, has been implicated in
regulating cell differentiation pathways (Casado et al.,
1996). Eventually, rupture of the lens capsule occurs
which has possibly been weakened by proteases released
from degenerating lens fibre cells.
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The precise mechanism by which loss of SPARC results
in rupture of the lens is not clear. SPARC/BM40 has been
detected in the mouse and bovine lens capsule (Dziadek
et al., 1986; Sawhney, 1995) and is secreted by bovine
lens epithelial cells (Sawhney, 1995). The level of SPARC
protein in the mouse lens capsule is only ~2.5 pmol/mg
protein, making it extremely difficult to detect by indirect
immunofluorescence (Dziadek et al., 1986). SPARC binds
to type IV collagen which is a major structural component
of the lens capsule (Iwata et al., 1995). It has been
suggested that SPARC, through its binding to type IV
collagen, may play an important role in the assembly and/
or stabilization of the ECM. Although we found no
qualitative changes in collagen α1,2(IV) or other ECM
proteins in mutant lens capsules, it is still possible that
the absence of SPARC can weaken the capsule sufficiently
to contribute to its eventual rupture.
Absence of a major developmental phenotype in
homozygous mutants
The phenotype of the mutant mice was somewhat unexpec-
ted based on the widespread expression pattern of SPARC
during mouse embryonic development and in adult tissues
(Holland et al., 1987; Howe et al., 1988; Sage et al.,
1989a; for a review, see Lane and Sage 1994). Alizarin
red-stained skeletons from mutant embryos and adults were
indistinguishable from wild-type, even though SPARC can
account for up to 3% of total bone protein (Termine et al.,
1984). It is possible that subtle phenotypic differences
will be identified following physiological perturbations.
Loss of SPARC causes cataracts
Fig. 5. Development of cataracts in Sparctm1Cam mutant mice. (A) Gross appearance of lens cataract. (a) The lens of a wild-type MF1 mouse at 1 year of
age. (b) The lens of a Sparctm1Cam mutant mouse also at 1 year of age with opacity of the lens. (B) Histological appearance of the lens in mutant mice.
Sections at increasing magnification of lenses from wild-type MF1 (a, c and e) and Sparctm1Cam mutant mice (b, d and f), both at age 10.5 months. (a)
Wild-type mouse lens, scale bar 5 600 µm. (b) Sparctm1Cam mutant mouse lens also with an obvious sub-capsular cataract. Scale bar 5 600 µm. (c) Wild-
type mouse lens at higher magnification showing the equatorial bow of epithelial cells differentiating into fibre cells. Scale bar 5 75 µm. (d) Similar
region from a Sparctm1Cam mutant mouse, with vacuolation and lack of a coherent bowing of epithelial cells (arrowed). Scale bar 5 150 µm. (e) Posterior
region of a wild-type lens, demonstrating that there are normally no epithelial cells present in this region. Scale bar 5 75 µm. (f) Similar region from a
Sparctm1Cam mutant mouse, showing epithelial cells in the posterior region (arrowed). Scale bar 5 150 µm.
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Thus, studies to assess whether wound healing or bone
strength and fracture repair are affected in Sparctm1Cam
mutant mice are underway. Perhaps SPARC plays a role
in protection against infection, for example enhancing
cellular responses to pathological stimuli. Alternatively, it
may be that SPARC does not serve a major role during
embryogenesis but its sequence has been conserved during
Table I. Age of onset of cataract formation
Age No. of mice with cataracts of each genotype
(months)
1/1 1/– –/–
10–20 0/5* ND 51/51α
6–9 0/7 0/5 17/18β
0/2*
,6 0/8 0/3 0/6
All mice of similar age were littermate controls apart from the group
marked * which consisted of age-matched controls of similar genetic
background. Mice in the α group showed the most dramatic lens
degeneration that was visually obvious and/or histologically
determined, while mice in the β group showed more subtle but clear
bilateral cataract formation as revealed by histological analysis. All
other mice had normal histology that could not be distinguished from
wild-type. No sex-related differences were observed.
Fig. 6. Progression of cataract formation. Both lenses from a Sparctm1Cam mutant mouse at 18 months of age with differing severity of cataract
development in each eye. (a) Lens with moderate signs of cataract development showing the initiation of vacuolation. The arrow points to
intracellular vacuoles forming within a differentiating epithelial cell in the equatorial region. Scale bar 5 37.5 µm. (b) A different section of the
same lens showing more extensive vacuolation (arrowed). Apart from this portion of the lens, there were no other signs of cataract formation. Scale
bar 5 75 µm. (c) The other lens from the same mouse shows much more dramatic vacuolation and posterior rupture of the lens capsule (arrowed).
Scale bar 5 150 µm. (d) The posterior region of the same lens as in (c) is shown along with the retinal layer. The distortion of the retina (arrow) is
secondary to the massive disruption of lens structure. Scale bar 5 75 µm.
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evolution due to a selective advantage conferred upon the
fitness and survival of the adult. This possibility is
strengthened by the eye phenotype observed in the SPARC-
deficient mice, which would be a serious impediment to
survival in the wild, and would be strongly selected against,
although this would not explain why Sparc expression is
widely observed during embryogenesis in many
different phyla.
Alternatively, it is possible that the lack of a lethal
phenotype in Sparctm1Cam mutant animals is due to func-
tional rescue by a related protein or proteins. The concept
of functional redundancy implies that different proteins
have overlapping expression patterns and share similar
functional domains. The C-terminus of SPARC, which
contains the Ca21-binding EC domain (Maurer et al.,
1995), is also present in at least four other extracellular
proteins which also contain a nearby follistatin-like (FS)
domain. These proteins include SC1 (Johnston et al.,
1990; McKinnon et al., 1996), the human testicular
proteoglycan TESTICAN (Alliel et al., 1993), trans-
forming growth factor-β-induced protein TSC36
(Shibanuma et al., 1993) and QR1 (Casado et al., 1996).
Preliminary data also indicate the existence of at least
three additional members of this family (C.Vannahme
and P.Maurer, personal communication). SC1 is a good
Loss of SPARC causes cataracts
Fig. 7. Electron micrographs of the lens capsule in Sparctm1Cam mutant mice. Electron microscopy studies of lenses from wild-type (a and c) and
Sparctm1Cam mutant mice (b, d, e and f) revealed striking differences. (a) The posterior capsule region from a 9-month-old MF1 wild-type mouse.
(b) The posterior capsule region from a 7-month-old mutant mouse showing protrusion of material into the capsule (arrowed). (c) The anterior
region of a lens from a 5-month-old wild-type littermate showing epithelial cells with typical flattened nuclei (white arrow) adjacent to the capsule.
(d) The anterior region from an 8-month-old mutant mouse shows epithelial cells with more rounded nuclei (arrowed) and the initiation of vacuole
formation. (e) The equatorial bow region from a 7-month-old mutant shows extensive cellular debris probably originating from rupture of
differentiating epithelial and fibre cells. (f) The equatorial bow region from an 8-month-old mutant shows intracellular vacuolation in differentiating
epithelial cells that appears to displace the nuclei within these cells (arrowed). All micrographs, 24003 magnification, except (e) 16003. c 5
capsule; v 5 vacuole.
candidate to compensate for loss of SPARC since it is co-
expressed in a range of tissues (Girard and Springer, 1996;
McKinnon et al., 1996) and has an identical intron–exon
boundary for the EC- and FS-coding domains, indicating
that the two genes may be derived from a common ancestor
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(McKinnon et al., 1996). Mice carrying disruptions in
both the Sparc and Sc1 genes are being generated to
assess the possibility of functional overlap. Functional
rescue may also account for the lack of a developmental
phenotype in mice with null mutations in other ECM
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Fig. 8. Immunohistochemical localization of extracellular matrix
proteins in the lens capsule from wild-type and mutant mice. Cryostat
sections were analysed for the following proteins: (a and g) laminin 1;
(b and h) collagen α1/2(IV); (c and i) entactin; (d and j) perlecan;
(e and k) pre-immune negative control; (f and l) extra-ocular muscles
stained with laminin 1. (a–f) 1/1, wild-type mice; (g–l) –/–,
Sparctm1Cam mutant mice. Bar 5 50 µm.
proteins, such as tenascin-C (Saga et al., 1992), thrombo-
spondin 1 (Kyriakides et al., 1998), vitronectin (Zheng
et al., 1995) and osteopontin (Liaw et al., 1998). Thus,
there seems to be considerable developmental plasticity
associated with loss of ECM molecules, perhaps caused
by functional overlap.
Materials and methods
Construction of the Sparc targeting vector, pS2
A 14.5 kb fragment containing Sparc exons 6–10 was released from the
genomic cosmid p30g3 (McVey et al., 1988) by HindIII digestion. A
5.5 kb EcoRI fragment containing exon 6 was subcloned from this
HindIII fragment into a modified pBluescript KS1 (Stratagene) vector
with the PstI and XmaI sites removed from the polylinker. Digestion
with XmaI and PstI allowed removal of the Sparc exon 6. This was
replaced with a 4.4 kb XmaI–SalI fragment from the plasmid ROSA
β-gal (kind gift from Dr P.Soriano) which has a splice acceptor placed
upstream of a promoterless β-galactosidase gene and a PGK promoter-
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driven neomycinr sequence (Friedrich and Soriano, 1991). The LacZ
gene is not in-frame with the Sparc coding sequence.
Generation of targeted ES cell clones and chimeric mice
CCB ES cells (Robertson et al., 1986) were cultured on neomycin-
resistant primary embryonic fibroblast feeder layers in Dulbecco’s
modified Eagle’s medium (DMEM, Gibco-BRL) supplemented with
10% fetal bovine serum (FBS, Sera-labs), 10% newborn calf serum
(NBCS, Sigma), 2 mM glutamine (Gibco-BRL) and 0.1 mM β-mercapto-
ethanol (Sigma) in a humidified incubator (Gallenkamp) at 37°C in 5%
CO2. A total of 1310
7 cells were electroporated with 25 µg of NotI-
linearized targeting construct using a Bio-Rad Gene Pulser (250 µF,
250 V). After electroporation, the ES cells were plated onto mitotically
inactivated feeder layers and neomycin-resistant clones were selected in
the presence of 150 µg/ml G418 (Sigma) with daily replacement of
medium for 12 days. Resistant colonies were isolated and plated on
fresh feeder layers in individual wells of a 24-well dish (Nunc) and
grown to confluency. Genomic DNA was isolated from individual clones,
digested with BamHI and Southern blotted (Sambrook et al., 1989).
These blots were hybridized with the external probe E1300, a 1.3 kb
EcoRI fragment located 800 bp external to the 39 flank of the targeting
vector. Southern screening of 123 G418-resistant colonies led to the
identification of 14 independently targeted clones. Targeting was con-
firmed by BamHI and PstI digestions and hybridization with an internal
neo probe and an exon 6-specific probe. The targeted Sparc allele is
defined as Sparctm1Cam according to the nomenclature guidelines issued
by the Jackson Laboratory.
Two independently targeted clones were used to generate chimeric
mice as previously described (Bradley, 1987). Male chimeras were mated
to non-agouti MF1 (Harlan Olac) mice and agouti offspring screened
for transmission of the disrupted Sparc allele. Germline chimeras were
obtained from one of the targeted ES clones.
Northern analysis
Embryos from timed matings were collected at 15.5 d.p.c. (days post-
coitum). Half of each embryo was used to prepare DNA for genotyping,
and total RNA was extracted from the remainder using the single step
guanidinium thiocyanate–phenol technique (Chomczynski and Sacchi,
1987). Twenty µg of this RNA was analysed on a formaldehyde gel and
blotted as described by Sambrook et al. (1989).
Western analysis
Protein was extracted from testes by homogenization in 50 mM Tris–
HCl pH 7.5, 250 mM NaCl, 1 mM EDTA, 0.5 mM dithiothreitol (DTT)
and proteinase inhibitor cocktail [0.5 mM phenylmethylsulfonyl fluoride
(PMSF), 0.5 µg/ml leupeptin, 1 µg/ml trypsin inhibitor, 0.5 µg/ml
aprotinin, 40 µg/ml bestatin]. Protein concentrations were determined
using the Coomassie Protein Assay Reagents from Pierce, and 100 µg
of each sample were separated by SDS–PAGE as described by Laemmli
(1970). Following electrophoresis, proteins were transferred to nitrocellu-
lose as described by Towbin et al. (1979). The filter was blocked with
10% (w/v) dried milk in TBST (10 mM Tris–HCl pH 8.0, 150 mM
NaCl, 0.1% Tween-20) and incubated with primary antibody for at least
1 h. The affinity-purified rabbit antibody (1064 1E) against recombinant
mouse SPARC/BM40 was a kind gift from Dr Rupert Timpl and was
used at a dilution of 1:200 in TBST. The monoclonal β-actin antibody
(Sigma) was used at 1:2000 in TBST. Proteins were visualized using the
ECL detection system from Amersham after addition of the horseradish
peroxidase-conjugated secondary antibody (Sigma)
Histology and skeletal analysis
Mice were killed by CO2 asphyxiation and organs fixed in 4% formalde-
hyde in phosphate-buffered saline. Organs were embedded in paraffin
wax and 5 µm sections cut and stained with haematoxylin and eosin.
Skeletons were prepared and stained with Alizarin red as described by
Hogan et al. (1994). Eyes were removed with tweezers post-mortem
and initially fixed for several days in 70% ethanol, followed by 30, 50
and 70% alcohol fixations for 2 h each (with the 70% alcohol fixation
usually proceeding overnight). This was followed by three changes of
methanol on the second day, followed by an overnight wash in chloro-
form. On the third day, the eyes were placed in three changes of molten
paraffin wax (BDH) at 62°C and cooled in ice-cold water to preserve
the lens. Sections were cut at 3–4 µm onto glass slides coated with
0.25% gelatin, placed on a hot plate between 35 and 40°C for 30 min,
and then dried overnight at 37°C.
Loss of SPARC causes cataracts
Electron microscopy
Eyes were fixed by immersion for 24 h at 23°C in a solution of 2.5%
glutaraldehyde and 6% sucrose, buffered to pH 7.2 with 50 mM sodium
cacodylate. Specimens were post-fixed in OsO4 buffered with 150 mM
sodium–potassium phosphate (pH 7.4), embedded in Spurr resin (Spurr,
1969) and sectioned with a glass knife for electron microscopy. Sections
were examined using a JEM 100B electron microscope (JEOL).
Immunohistochemistry
Mouse eyes were snap-frozen in liquid nitrogen in OCT medium and
cryostat sectioned. The indirect immunofluorescence method and source
of the antibodies are as described in Miner and Sanes (1996) and Miner
et al. (1997).
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